Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,068,125 | 0 | 160,016 | 244,970 | 73.07% | +84,954 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,025,000 | 1,025,000 | 0 | 14,883 | 22,150 | 6.61% | +7,267 |
| Verona Pharma plc (VRNA) | 1,115,352 | 1,115,352 | 0 | 18,180 | 22,173 | 6.61% | +3,993 |
| Compass Pathways Plc (CMPS)(CMPS) | 964,500 | 964,500 | 0 | 7,137 | 8,439 | 2.52% | +1,302 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 7,052 | 8,319 | 2.48% | +1,266 |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | 2,483 | 3,505 | 1.05% | +1,022 |
| Spruce Biosciences, Inc. (SPRB) | 1,205,511 | 1,205,511 | 0 | 2,724 | 3,532 | 1.05% | +808 |
| Biomea Fusion Inc (BMEA)(BMEA) | 798,757 | 798,757 | 0 | 10,991 | 11,598 | 3.46% | +607 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,541,009 | 0 | 3,405 | 3,837 | 1.14% | +432 |
| Marker Therapeutics, Inc. (MRKR)(MRKR) | 314,286 | 314,286 | 0 | 1,427 | 1,729 | 0.52% | +302 |
| Atreca Inc. (BCEL) | 387,653 | 387,653 | 0 | 101 | 51 | 0.02% | -50 |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | 300 | 164 | 0.05% | -136 |
| Avrobio, Inc. (AVRO) | 1,009,779 | 1,009,779 | 0 | 1,555 | 1,373 | 0.41% | -182 |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | 1,878 | 1,522 | 0.45% | -356 |
| Aeglea Biotherapeutics Inc (AGLE)(SYRE) | 67,645 | 0 | -67,645 | 829 | 0 | — | -829 |
| Aclaris Theraputics Inc (ACRS)(ACRS) | 434,455 | 434,455 | 0 | 2,976 | 456 | 0.14% | -2,520 |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | 6,743 | 1,418 | 0.42% | -5,325 |